Why Your LIMS Migration Fails

📈 95% user satisfaction, 30% faster biomarker interpretation—this is what happens when you stop juggling legacy LIMS and move to unified SaaS.

Our approach: rapid onboarding, CI/CD-driven modernization, and zero-downtime migration.
Result? 20+ trial sites onboarded globally, 40%+ usage growth in just months.

Ready to future-proof your lab stack? DM us for a tailored roadmap.

Transcript

1. (and how to guarantee it doesn’t) LIMS migration lessons from CRO and biotech teams Why Your LIMS Migration Fails Lab infomatics Life science
2. Vendor delays and roadmap paralysis: timelines slip, priorities shift, compliance risks multiply Integration bottlenecks: automation stalls, reproducibility suffers, and scale becomes impossible
 Fragmented lab informatics: LIMS, ELN, and SDMS don’t talk, forcing manual workarounds What Derails Migration Before It Starts
3. Zero-downtime, phased migration: parallel systems first, unified platform next API-first architecture: LIMS, ELN, SDMS, and instruments fully connected Rapid, low-touch engagement: senior healthtech engineers embedded from week one What Actually Works
4. 30% faster biomarker analysis post-launch Visualization of 1M+ genomic samples Transitioned from legacy LIMS to scalable data platform in 3 months Case in Point: Genomics Data Platform
5. DM us for a proven migration playbook Built from real deployments, not theory Move Faster with Less Risk CRO Biotech HealthTech